Fulfilling its promise to introduce state-of-the-art services from international medical brands to the Qatari market, Ali Bin Ali (ABA) Group’s QCare Medical announced the signing of an exclusive agreement with Endocare Inc. USA for the distribution of its Endocare™ Cryoablation technology in Qatar.
A prime vision of ABA Group has been to create a comprehensive, world-class healthcare system in Qatar, whose services are accessible to the whole population.
Keeping this vision in mind and with the aim of complying with the Qatar National Health Strategy (NHS) 2017-2022, QCare in May 2017 proudly installed the first Endocare™ cryoablation machine – Cryocare Cs – in the Middle East at Hamad General Hospital.
Well known Urologist Dr. Franco Lugnani flew in to Doha to conduct a demonstration and training for the medical teams of Dr. Ahmed Omar, Head of Radiology department & Dr. Khalid Al Rumaihi, Head of Urology department at Hamad General Hospital. On May 25, the team performed 3 successful surgeries with the Cryocare Cs .
Speaking about this strategic agreement, Mr. Zuhdi Z Al-Jaouni, General Manager of Qcare Medical & ABA Medical, said: “This exclusive agreement is a particularly important one as a growing amount of evidence supports the use of cryotherapy for patients with localized prostate cancer following radiation therapy.”
Endocare Inc. is a medical device company focused on the development of minimally invasive technologies for tissue and tumor ablation.
Endocare™ cryoablation therapy focuses on the development of a specialized type of cryotherapy for the minimally invasive treatment of cancer with a faster and easier-to-operate cryoablation system for freezing cancerous tumors and tissue.
Endocare remains the market leader in this category, as this new system uses nitrogen as the freezing and tumor-destroying element. The nitrogen, called “critical nitrogen” because it works in a unique form at the critical point where gas nearly becomes liquid, is also more powerful and readily available in surgical suites than argon, the freezing element in Endocare’s current market-leading cryoablation systems.